- Home
- MERC vs MDAI Comparison
MERC vs MDAI Comparison
Compare MERC & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MERC | MDAI |
|---|---|---|
| Founded | 1968 | 2013 |
| Country | Canada | United States |
| Employees | N/A | 65 |
| Industry | Paper | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.2M | 53.8M |
| IPO Year | 2005 | N/A |
Fundamental Metrics
Financial Performance| Metric | MERC | MDAI |
|---|---|---|
| Price | $0.64 | $1.64 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $2.25 | ★ $3.00 |
| AVG Volume (30 Days) | ★ 785.0K | 260.4K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | ★ 7.01% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,169,145,000.00 | N/A |
| Revenue This Year | $13.75 | N/A |
| Revenue Next Year | $10.12 | $23.50 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 25.50 | N/A |
| 52 Week Low | $0.53 | $1.18 |
| 52 Week High | $4.47 | $2.97 |
Technical Indicators
Market Signals| Indicator | MERC | MDAI |
|---|---|---|
| Relative Strength Index (RSI) | 43.40 | 37.53 |
| Support Level | N/A | $1.62 |
| Resistance Level | $0.81 | $1.77 |
| Average True Range (ATR) | 0.07 | 0.08 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 43.61 | 7.55 |
Price Performance
Historical ComparisonAbout MERC Mercer International Inc.
Mercer International Inc is a forest products company with two reportable operating segments in pulp and solid wood. The pulp segment consists of the manufacture, sale, and distribution of pulp, electricity, and chemicals. The company has a geographical presence in the USA, Germany, China, and Other countries, where the maximum of revenue is generated from the China. The majority of the revenue is generated from the Pulp segment.
About MDAI Spectral AI Inc.
Spectral AI Inc is an AI company focused on predictive medical diagnostics. Its DeepView System uses proprietary AI algorithms to distinguish between fully damaged, partially damaged and healthy human tissue characters invisible to the naked eye, at the initial time point of wound presentation. The DeepView System delivers a binary prediction on the wound's capacity to heal or not-heal by a specified time point in the future. The company focuses on the burn indication which is supported by the BARDA PBS contract.